STOCK TITAN

Dakota Gold Corp. 8-K Filings

DC NYSE

Every 8-K that Dakota Gold Corp. (DC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow DC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DC filings page.

Rhea-AI Summary

Dakota Gold Corp. announced a planned CEO transition tied to the advancement of its Richmond Hill Gold Project. Dr. Robert Quartermain will retire as Chief Executive Officer effective August 18, 2026, while continuing as Director and Board Co-Chair. The Board has appointed current President and COO Jack Henris, a 35-year mining veteran and South Dakota School of Mines graduate, to become CEO and join the board on the same date.

Henris’s compensation package includes an annual base salary of $360,000, a discretionary bonus opportunity equal to 75% of base salary tied to performance goals, and at least $630,000 in long-term incentive awards, subject to vesting. Management highlights progress at Richmond Hill to pre-feasibility stage, notes having secured funding to execute planned programs through 2028, and cites a cash balance of $107 million in March 2026 financial statements, supporting a goal of moving the project toward potential production as soon as 2029. Additional leadership adjustments include planning to appoint Shawn Campbell as Chief Development Officer and continued oversight of permitting by SVP and Chief Legal Officer Amy Koenig.

Rhea-AI Summary

Dakota Gold Corp. reported the results of its 2026 annual meeting of stockholders held on May 27, 2026. Stockholders elected seven director nominees, including Jennifer Grafton, Brian Iverson, and Robert Quartermain, with each receiving more votes "For" than "Withheld," alongside substantial broker non-votes.

Stockholders also approved a second proposal, with 96,843,306 votes "For," 261,929 "Against," and 94,190 "Abstain." The company remains an emerging growth company, and its common stock and warrants continue to trade on NYSE American under the symbols DC and DC.WS.

Rhea-AI Summary

Dakota Gold Corp. announced that its publicly traded warrants, each exercisable for one share of common stock at an exercise price of $2.08, will expire on March 15, 2026 pursuant to their original terms. Trading in the warrants under the symbol “DC.WS” on the NYSE American will cease before the markets open on or about March 13, 2026 to allow for timely settlement of any exercises before expiration.

The NYSE American has confirmed it intends to file Form 25 to delist and deregister the warrants under Section 12(b) of the Exchange Act. Dakota Gold’s common stock will continue to trade on the NYSE American under the symbol “DC”.

Rhea-AI Summary

Dakota Gold Corp. filed an update announcing that its Board of Directors has appointed Brian G. Iverson as a director, effective March 1, 2026. He is expected to stand for election by stockholders at the 2026 Annual Meeting of Stockholders.

Mr. Iverson will participate in the company’s non-employee director compensation program described in the proxy statement for the 2025 Annual Meeting of Stockholders. The company states there are no special arrangements behind his appointment, no family relationships with current directors or executives, and no material related-party transactions requiring disclosure.

Rhea-AI Summary

Dakota Gold Corp. completed an underwritten public offering of 12,336,000 shares of common stock at $6.08 per share, generating estimated net proceeds of about $70.55 million after discounts and expenses. The company also granted underwriters a 30-day option to buy up to 1,850,400 additional shares.

The shares were issued under an effective shelf registration statement on Form S-3 and a February 9, 2026 prospectus supplement. Dakota Gold plans to use the net proceeds for working capital and other general corporate purposes. The offering closed on February 11, 2026.

Rhea-AI Summary

Dakota Gold Corp. has changed its independent auditor, appointing Deloitte & Touche LLP on November 18, 2025 for the fiscal year ending December 31, 2025 and dismissing Ernst & Young LLP. EY’s audit reports for the years ended December 31, 2024 and 2023 contained no adverse opinions, disclaimers, or qualifications.

The company reports there were no disagreements with EY on accounting principles, financial statement disclosure, or audit procedures through November 18, 2025. Dakota Gold also states it did not consult with Deloitte on accounting or audit matters before the appointment. EY’s confirmation letter to the SEC is included as an exhibit.

Rhea-AI Summary

Dakota Gold Corp. established an at-the-market equity program, entering an Equity Distribution Agreement with BMO Capital Markets, Canaccord Genuity, and H.C. Wainwright. The program permits the Company to offer and sell shares of common stock with an aggregate offering price of up to $50,000,000, from time to time, through the Sales Agents acting as agent.

Sales commissions will be up to 3.0% of gross proceeds on shares sold under the agreement. The offering is registered under the Company’s Form S-3 shelf (File No. 333-288922), as supplemented by a prospectus supplement dated November 13, 2025. The Company may sell shares based on market conditions and is not obligated to sell any shares. Either party may terminate the agreement by written notice.

Rhea-AI Summary

Dakota Gold Corp. disclosed a new employment agreement with CEO Dr. Robert Quartermain. The agreement sets an annual base salary of US$312,000, payable in Canadian dollars at the prevailing exchange rate, and a one-year term commencing August 19, 2025. Dr. Quartermain is eligible to participate in the company’s securities-based compensation plans, including the 2022 Stock Incentive Plan.

If terminated for cause or if he resigns without good reason during the employment period, Dr. Quartermain is entitled only to defined accrued benefits. The filing states that any other termination will not trigger additional severance payments. The agreement includes customary protections such as confidentiality, non-disparagement, cooperation covenants, indemnification aligned with company by-laws, D&O insurance, equitable relief, and governing law in the Province of British Columbia with applicable Canadian laws.